Your browser doesn't support javascript.
loading
The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
Steinway, Steven N; Dang, Hien; You, Hanning; Rountree, C Bart; Ding, Wei.
Afiliação
  • Steinway SN; Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
  • Dang H; Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
  • You H; Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
  • Rountree CB; Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
  • Ding W; Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America.
PLoS One ; 10(5): e0128159, 2015.
Article em En | MEDLINE | ID: mdl-26000702
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Sobrevivência Celular / Carcinoma Hepatocelular / Proteínas Proto-Oncogênicas c-met / Receptor ErbB-3 / Receptores ErbB / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Sobrevivência Celular / Carcinoma Hepatocelular / Proteínas Proto-Oncogênicas c-met / Receptor ErbB-3 / Receptores ErbB / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article